ENDRA Life Sciences NDRAW 深 沪
已收盘 05-12 16:00:00 美东时间
0.03
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.03
- 总市值 124.92万
- 52周最高 0.72
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.01
- 委 比 0.00%
- 总股本 4164.02万
- 历史最高 2.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.01
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ASP Isotopes says PET Labs, Renergen, isotope facilities nearing key milestones
ASP Isotopes (ASPI) up 4.3% pre-market Tuesday after releasing a shareholder letter outlining operational progress across its business units ahead of Q2 financial results. ASP (ASPI) said PET Labs pos...
08-04 21:27
ASP Isotopes Issues Letter to Shareholders
ASP Isotopes Inc. reported strong progress across its business units, including 50% revenue growth in PET Labs, upcoming helium production at Renergen, and advancements in stable isotope enrichment. The company expects significant contributions to profitability from these divisions. Additionally, Renergen is set to become a Nasdaq-listed company through a reverse merger, and Quantum Leap Energy is pursuing a public listing. Alpa Theranostics is a...
08-04 12:00
ENDRA Life Sciences Plans Merger Creating Noble Africa Helium Platform
ENDRA Life Sciences ( ($NDRA) ) has shared an announcement. On June 25, 2026, A...
06-25 21:57
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
<p>Noble Africa LLC, a subsidiary of ASP Isotopes Inc., will merge with a subsidiary of ENDRA Life Sciences Inc. in a transaction expected to create Noble Africa Inc., a Nasdaq-listed company focused on Renergen’s Virginia Gas helium project. The merger, along with a concurrent private placement targeting $50 million in gross proceeds, aims to provide capital and market access for project development. ASP Isotopes will own approximately 89% of th...
06-25 13:30
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.
06-01 20:43
ENDRA Life Sciences Announces Strategic Private Placement Financing
The latest announcement is out from ENDRA Life Sciences ( ($NDRA) ). On May 27,...
05-28 18:37
ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from
05-18 20:04
